Cargando…

Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis

AIMS: Diabetic nephropathy (DN) is one of the main causes of chronic kidney disease (CKD), which increases the risk of cardiovascular diseases and progresses to end-stage renal failure. Thus, early diagnostic markers for diabetic patients are urgently needed to improve the prognosis of DN and predic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Li, Xue, Shuai, Wu, Meiyan, Dong, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479543/ https://www.ncbi.nlm.nih.gov/pubmed/36117980 http://dx.doi.org/10.3389/fmed.2022.914587

Ejemplares similares

Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes
por: Panduru, Nicolae M., et al.
Publicado: (2013)

Clinical Significance of Urinary Liver-Type Fatty Acid–Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients
por: Kamijo-Ikemori, Atsuko, et al.
Publicado: (2011)

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients
por: Nielsen, Stine Elkjaer, et al.
Publicado: (2010)

Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy
por: Viswanathan, V., et al.
Publicado: (2015)

Clinical evaluation of urinary liver-type fatty acid-binding protein for the diagnosis of renal diseases in dogs
por: TAKASHIMA, Satoshi, et al.
Publicado: (2021)

Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner
por: Kitada, Munehiro, et al.
Publicado: (2017)

Distinct Roles of Urinary Liver-Type Fatty Acid-Binding Protein in Non-Diabetic Patients with Anemia
por: Imai, Naohiko, et al.
Publicado: (2015)

Predictive Effects of Urinary Liver-Type Fatty Acid–Binding Protein for Deteriorating Renal Function and Incidence of Cardiovascular Disease in Type 2 Diabetic Patients Without Advanced Nephropathy
por: Araki, Shin-ichi, et al.
Publicado: (2013)

Correction: Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner
Publicado: (2017)

Urinary liver-type fatty acid binding protein and chronic kidney disease
por: Kamijo-Ikemori, A., et al.
Publicado: (2015)

Urinary Fatty Acid Binding Protein 3 Has Prognostic Value in Peripheral Artery Disease
por: Li, Ben, et al.
Publicado: (2022)

Relationship between Urinary Liver-Type Fatty Acid-Binding Protein (L-FABP) and Sarcopenia in Spontaneously Diabetic Torii Fatty Rats
por: Tanabe, Jun, et al.
Publicado: (2020)

The Role of Urinary Liver-Type Fatty Acid-Binding Protein in Critically Ill Patients
por: Cho, Eunjung, et al.
Publicado: (2013)

Current Metabolic Status Affects Urinary Liver-Type Fatty-Acid Binding Protein in Normoalbuminuric Patients With Type 2 Diabetes
por: Ito, Hiroyuki, et al.
Publicado: (2017)

Metabolic Dysfunctions of Intestinal Fatty Acids and Tryptophan Reveal Immuno-Inflammatory Response Activation in IgA Nephropathy
por: Wu, Hongwei, et al.
Publicado: (2022)

Renal expression and urinary excretion of liver‐type fatty acid‐binding protein in cats with renal disease
por: Katayama, Masaaki, et al.
Publicado: (2020)

Elevation of urinary liver-type fatty acid binding protein after cardiac catheterization related to cardiovascular events
por: Kamijo-Ikemori, Atsuko, et al.
Publicado: (2015)

Urinary liver‐type fatty acid‐binding protein as a prognostic marker in patients with acute heart failure
por: Sunayama, Tsutomu, et al.
Publicado: (2021)

Urinary liver‐type fatty acid‐binding protein: A hemodynamic index during extracorporeal membrane oxygenation
por: Ichibayashi, Ryo, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease Is not Related to the Incidence of Diabetic Nephropathy in Type 2 Diabetes
por: Zhan, Yu-Tao, et al.
Publicado: (2012)

Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease
por: Fridén, Michael, et al.
Publicado: (2022)

Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis—Literature Review
por: Ismaiel, Abdulrahman, et al.
Publicado: (2019)

Urinary adiponectin and progression of diabetic nephropathy in type 1 diabetes
por: Ha, Kyoung Hwa, et al.
Publicado: (2015)

Study of the Urinary TGF-β1 Profile in Diabetic Nephropathy: A Single-Center Experience From India
por: Kulkarni, Akshay R, et al.
Publicado: (2023)

Urinary liver‐type fatty acid‐binding protein is independently associated with graft failure in outpatient kidney transplant recipients
por: Yepes‐Calderón, Manuela, et al.
Publicado: (2020)

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Residual Renal Function Decline in Patients on Peritoneal Dialysis
por: Torigoe, Kenta, et al.
Publicado: (2020)

Urinary liver-type fatty acid-binding protein in two dogs with acquired Fanconi syndrome: A case report
por: Takashima, Satoshi, et al.
Publicado: (2022)

A systematic review and Meta-analysis of urinary extracellular vesicles proteome in diabetic nephropathy
por: Ding, Xiaonan, et al.
Publicado: (2022)

Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease
por: Xiao, Jieling, et al.
Publicado: (2021)

The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials
por: Chewcharat, Api, et al.
Publicado: (2020)

Circulating Levels of Adipocyte and Epidermal Fatty Acid–Binding Proteins in Relation to Nephropathy Staging and Macrovascular Complications in Type 2 Diabetic Patients
por: Yeung, Dennis C.Y., et al.
Publicado: (2009)

Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients
por: Fiseha, Temesgen
Publicado: (2015)

Glomerular Endothelial Cells Are the Coordinator in the Development of Diabetic Nephropathy
por: Li, Tingting, et al.
Publicado: (2021)

Diagnostic value of neutrophil gelatinase-associated lipocalin in diabetic nephropathy: a meta-analysis
por: Chen, Bin, et al.
Publicado: (2019)

Arterial Stiffness in Balkan Endemic Nephropathy, an Environmental Form of Aristolochic Acid Nephropathy
por: Premužić, Vedran, et al.
Publicado: (2018)

Effect of Omega-3 Fatty Acid on the Fatty Acid Content of the Erythrocyte Membrane and Proteinuria in Patients with Diabetic Nephropathy
por: Lee, Su Mi, et al.
Publicado: (2015)

Change in Liver Fibrosis Associates with Progress of Diabetic Nephropathy in Patients with Nonalcoholic Fatty Liver Disease
por: Terasaka, Yoshiko, et al.
Publicado: (2023)

Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes
por: Argyropoulos, Christos, et al.
Publicado: (2013)

Urinary nephrin linked nephropathy in type-2 diabetes mellitus
por: Rangaswamaiah, Hareesh, et al.
Publicado: (2022)

Urinary mitochondrial DNA may be useful in diagnosing early diabetic nephropathy
por: Xue, Li, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sj195n5plms8f73qdp03uob0fo